Leaflet POSACONAZOL MYLAN 100mg gastro-resistant tablets

Product code:
W68234009
Quantity:
24
Indicated for:
fungal infections
Route of administration:
oral
Substance:
posaconazole (azole antifungal)
ATC
J02AC04 — Antiinfectives for systemic use | Antimycotics for systemic use | Antimycotics for systemic use | Triazole derivatives

Precautions:

Dose adjustment in hepatic impairment

Dose adjustment in hepatic impairment

Dose adjustment may be needed in liver disease.

Major drug interactions

Major drug interactions

This medicine may have important interactions with other medicines.

Pregnancy warning

Pregnancy warning

Use during pregnancy only on medical advice.

Cardiac risk / QT prolongation / arrhythmias

Cardiac risk / QT prolongation / arrhythmias

This medicine may increase the risk of heart rhythm disturbances.


Posaconazole is an antifungal medication used for the prevention and treatment of severe fungal infections, such as invasive aspergillosis or oropharyngeal candidiasis.
It belongs to the triazole class and works by inhibiting the synthesis of ergosterol, an essential component of the fungal cell membrane, leading to fungal destruction.

Posaconazole is particularly indicated for immunocompromised patients, such as those who have undergone organ transplants or are undergoing chemotherapy.
The medication is available as an oral suspension, tablets, or injectable solution, with the dosage adjusted based on the severity of the infection and the patient's condition.

Common side effects include nausea, diarrhea, headaches, and elevated liver enzyme levels.
In rare cases, more serious adverse effects may occur, such as hepatotoxicity or severe allergic reactions.

It is important for patients to strictly follow their doctor's recommendations and undergo regular liver function tests during treatment.
Posaconazole may interact with other medications, so patients should inform their doctor about all treatments they are taking.

General data about POSACONAZOL MYLAN 100mg

Substance:
posaconazole
Date of latest medicines list:
01-06-2026
Product code:
W68234009
Concentration:
100mg
Pharmaceutical form:
gastro-resistant tablets
Quantity:
24
Product type:
Generic medicine
Price:
995.75 RON
Prescription status:
P-RF — Medicines dispensed with a medical prescription that is retained by the pharmacy and cannot be renewed.

Marketing authorisation

Manufacturer:
DELORBIS PHARMACEUTICALS LTD - CIPRU
Holder:
MYLAN PHARMACEUTICALS LIMITED - IRLANDA
Number:
12723/2019/09
Shelf life:
30 months

Concentrations available for posaconazole

  • 100mg
  • 300mg
  • 40mg/ml

Compensation lists for POSACONAZOL MYLAN 100mg Mylan

G10 (C1) - Leukemias, lymphomas and bone marrow aplasia, tumors

Price
995.75 RON
Copayment
995.75 RON
Patient
0.00 RON

GX (C1) - GENERIC (used in compensation list, C1, for another diagnosis)

Price
995.75 RON
Copayment
995.75 RON
Patient
0.00 RON

NHP 1.A (C2) - People with HIV/AIDS and post-exposure treatment

Price
995.75 RON
Copayment
995.75 RON
Patient
0.00 RON

NHP 9.1 (C2) - Spinal cord transplant

Price
995.75 RON
Copayment
995.75 RON
Patient
0.00 RON

NHP 9.7 (C2) - Outpatient treatment of transplant patients

Price
995.75 RON
Copayment
995.75 RON
Patient
0.00 RON